Maverick Capital’s Impax Laboratories, Inc. IPXL Stock Holding History

Maverick Capital’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-4,043,203	Closed	-$78.6M	–	315
2018 Q1	$78.6M	Sell	4,043,203 -3,284,595	-45%	-$64.5M	1.01%	21
2017 Q4	$122M	Buy	7,327,798 +833,500	+13%	+$15.3M	1.54%	21
2017 Q3	$132M	Sell	6,494,298 -665,038	-9%	-$12.7M	1.67%	20
2017 Q2	$115M	Buy	7,159,336 +7,054,136	+6,705%	+$104M	1.45%	25
2017 Q1	$1.33M	Buy	+105,200	New	+$1.27M	0.02%	107

Maverick Capital's IPXL Position: Q2 2018 in Review

Maverick Capital sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 4,043,203 shares — an estimated $78.6M sold.

Maverick Capital first reported a position in IPXL in Q1 2017 and held it in 5 quarters. The position peaked at $132M in Q3 2017. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Maverick Capital reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Maverick Capital sold 4,043,203 Impax Laboratories, Inc. shares in Q2 2018, an estimated $78.6M.
Maverick Capital first reported a position in Impax Laboratories, Inc. in Q1 2017 and held it in 5 quarters.
Maverick Capital's Impax Laboratories, Inc. position peaked at $132M in Q3 2017.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Maverick Capital's 13F filing for Q2 2018, filed 14 Aug 2018.